e-Drug3D

262

NANDROLONE


INN
NANDROLONE

(is an active metabolite)

cas 434-22-0
CLASS

METABOLISM
ANABOLIC
ANDROGENS

ROUTE (list)

-

ATC code

A14AB01
S01XA11

PK parameters

Tmax 72 HOUR (PMID15713722)
t1/2 228 HOUR

Target

TARGET ANDROGEN RECEPTOR

PDB
5KP4 (CRYSTAL STRUCTURE OF KETOSTEROID ISOMERASE FROM PSEUDOMONAS PUTIDA (PKSI) BOUND TO 19-NORTESTOSTERONE)

Ligand code = 6VW (link to the list of PDB complexes)

Download experimental 3D coordinates of 6VW with added hydrogens

DrugCentral

Androgen receptor UNIPROT P10275 AR

Download SDF file (8R,9S,10R,13S,14S,17S)-17-hydroxy-13-methyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one

Formula:
C18H26O2

Calculated chemical properties:

MW 274.39
NB_atoms 20
XLogP 3.49
PSA 37.763
NB_HD 1
NB_HA 2
fsp3 0.83
Lipinski(0=no;1=yes) 1

FDA
-

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL

e-Drug3D

1345

NANDROLONE PHENPROPIONATE

DISCONTINUED


INN
NANDROLONE PHENPROPIONATE

(has an active metabolite)

cas 62-90-8
CLASS

HORMONES
ANDROGENIC
AGONIST
ANABOLIC STEROID

ROUTE (list)

INJECTION

ATC code

A14AB01
S01XA11

PK parameters

Target

TARGET ANDROGEN RECEPTOR (AR)

DrugCentral

Androgen receptor UNIPROT P10275 AR

Download SDF file Estr-4-en-3-one, 17-(1-oxo-3-phenylpropoxy)-, (17.beta.)-

Formula:
C27H34O3

Calculated chemical properties:

MW 406.54
NB_atoms 30
XLogP 5.67
PSA 41.545
NB_HD 0
NB_HA 3
fsp3 0.63
Lipinski(0=no;1=yes) 0

FDA
NDA 086386 (pdf not found) INN (NANDROLONE PHENPROPIONATE) NANDROLONE PHENPROPIONATE (WATSON LABS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 087488 (pdf not found) INN (NANDROLONE PHENPROPIONATE) NANDROLONE PHENPROPIONATE (WATSON LABS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 089297 (pdf not found) INN (NANDROLONE PHENPROPIONATE) NANDROLONE PHENPROPIONATE (QUAD PHARMS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 089298 (pdf not found) INN (NANDROLONE PHENPROPIONATE) NANDROLONE PHENPROPIONATE (QUAD PHARMS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 011891 (pdf not found) INN (NANDROLONE PHENPROPIONATE) DURABOLIN (ORGANON USA INC) APPROVAL= AP YEAR= 1959 NEWMOLECULARENTITY DISCONTINUED

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL

e-Drug3D

1346

NANDROLONE DECANOATE

DISCONTINUED


INN
NANDROLONE DECANOATE

(has an active metabolite)

cas 360-70-3
CLASS

HORMONES
ANDROGENIC
ANABOLIC
AGONIST

ROUTE (list)

INJECTION

ATC code

A14AB01
S01XA11

PK parameters

Solubility

PRACTICALLY INSOLUBLE IN WATER


Target

TARGET ANDROGEN RECEPTOR (AR)

DrugCentral

Androgen receptor UNIPROT P10275 AR

Download SDF file Estr-4-en-3-one, 17-[(1-oxodecyl)oxy]-, (17.beta.)-

Formula:
C28H44O3

Calculated chemical properties:

MW 428.63
NB_atoms 31
XLogP 7.18
PSA 41.545
NB_HD 0
NB_HA 3
fsp3 0.86
Lipinski(0=no;1=yes) 0

FDA
NDA 087519 (pdf not found) INN (NANDROLONE DECANOATE) NANDROLONE DECANOATE (EPIC PHARMA LLC) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 087598 (pdf not found) INN (NANDROLONE DECANOATE) NANDROLONE DECANOATE (WATSON LABS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 087599 (pdf not found) INN (NANDROLONE DECANOATE) NANDROLONE DECANOATE (WATSON LABS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 088554 (pdf not found) INN (NANDROLONE DECANOATE) NANDROLONE DECANOATE (WATSON LABS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 089248 (pdf not found) INN (NANDROLONE DECANOATE) NANDROLONE DECANOATE (QUAD PHARMS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 089249 (pdf not found) INN (NANDROLONE DECANOATE) NANDROLONE DECANOATE (QUAD PHARMS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 089250 (pdf not found) INN (NANDROLONE DECANOATE) NANDROLONE DECANOATE (QUAD PHARMS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 013132 (pdf not found) INN (NANDROLONE DECANOATE) DECA-DURABOLIN (WOODWARD SPECL) APPROVAL= AP YEAR= 1962 DISCONTINUED
NDA 086385 (pdf not found) INN (NANDROLONE DECANOATE) NANDROLONE DECANOATE (WATSON LABS) APPROVAL= AP YEAR= 1983 DISCONTINUED
NDA 086598 (pdf not found) INN (NANDROLONE DECANOATE) NANDROLONE DECANOATE (WATSON LABS) APPROVAL= AP YEAR= 1983 DISCONTINUED
NDA 088128 (pdf not found) INN (NANDROLONE DECANOATE) NANDROLONE DECANOATE (WATSON LABS) APPROVAL= AP YEAR= 1983 DISCONTINUED
NDA 088317 (pdf not found) INN (NANDROLONE DECANOATE) NANDROLONE DECANOATE (ABRAXIS PHARM) APPROVAL= AP YEAR= 1983 DISCONTINUED
NDA 088290 (pdf not found) INN (NANDROLONE DECANOATE) NANDROLONE DECANOATE (ABRAXIS PHARM) APPROVAL= AP YEAR= 1989 DISCONTINUED
NDA 091252 (pdf not found) INN (NANDROLONE DECANOATE) NANDROLONE DECANOATE (AM REGENT) APPROVAL= AP YEAR= 2010 DISCONTINUED

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL